版本:
中国

BRIEF-Astellas Pharma to acquire Ogeda SA

April 3 Astellas Pharma Inc:

* under agreement, Astellas has agreed to pay up to a total of eur 800 million

* Astellas will make an initial payment of eur 500 million in consideration of 100% of equity in Ogeda at closing of transaction

* Ogeda shareholders will be eligible to receive additional eur 300 million with attainment of certain milestones for fezolinetant

* Astellas is still reviewing impact of this transaction on its financial forecasts for fiscal year ending March 31, 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐